![OncoPrecision](https://parsers.vc/logo/c1907123-9721-4d81-8457-9a5a8719495e-4.jpg)
We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each patient and pharmaceutical companies develop transformational therapies.
Location: Argentina, Autonomous City of Buenos Aires
Member count: 11-50
Total raised: $6.85M
Founded date: 2020
Investors 1
Date | Name | Website |
30.01.2023 | Creative V... | creativeve... |
Funding Rounds 3
Date | Series | Amount | Investors | Deal News |
01.11.2022 | Seed | $3.3M | - | finsmes.co... |
31.07.2022 | Seed | $3.3M | - | - |
16.02.2021 | Pre-Seed | $250K | IndieBio | - |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
01.11.2022 | OncoPrecis... | OncoPrecision, a New York, NY ... | Argentina ... | - | finsmes.co... |
17.03.2021 | From impro... | Ultra-precise cancer therapies... | indiebio, ... | Greg Kumpa... | techcrunch... |